Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia

Keyphrases

• 1H-MRS 28%
• AIMS™ 14%
• Between-group 14%
• Causal Factors 14%
• Endogenous Glucose Production 28%
• Fatty Acids 14%
• Glucose Level 14%
• Glucose Uptake 14%
• Glycerol 14%
• Hepatic Insulin Sensitivity 28%
• Hepatic Steatosis 100%
• High-dose Insulin 14%
• Hyperinsulinemic-euglycemic Clamp 14%
• Hypobetalipoproteinemia 100%
• Insulin 28%
• Insulin Infusion 28%
• Insulin Level 14%
• Insulin Resistance 100%
• Insulin Sensitivity 14%
• Intercellular Lipid 14%
• Lipolysis 14%
• Liver Fat 14%
• Localized Proton Magnetic Resonance Spectroscopy 14%
• Low-dose Insulin 14%
• Metabolic Derangements 14%
• Moderate to Severe 28%
• Per Se 14%
• Peripheral Insulin Sensitivity 28%
• Production Level 14%
• Stable Isotopes 14%
• Triacylglycerol 14%
• Trial Registration 14%
• Whole-body 14%

INIS

• comparative evaluations 16%
• control 33%
• doses 16%
• excretion 8%
• fats 8%
• fatty acids 8%
• glucose 33%
• glycerol 8%
• hypothesis 8%
• infusion 16%
• insulin 100%
• levels 16%
• lipids 8%
• liver 100%
• magnetic resonance 8%
• males 8%
• patients 33%
• people 100%
• production 16%
• protons 8%
• reduction 8%
• sensitivity 25%
• spectroscopy 8%
• stable isotopes 8%
• suppression 8%
• uptake 8%

Biochemistry, Genetics and Molecular Biology

• Drug Megadose 14%
• Gluconeogenesis 28%
• Glucose Level 14%
• Glucose Transport 14%
• Glycerol 14%
• Hypobetalipoproteinemia 100%
• Insulin Level 14%
• Insulin Resistance 100%
• Insulin Sensitivity 42%
• Lipid 14%
• Lipolysis 14%
• Low Drug Dose 14%
• Magnetism 14%
• Triglyceride 14%